Clinical Study of AFN50 Injection in the Autoimmune Diseases

Clinical trial NCT07408336 · RECRUITING

Trial details

NCT number: NCT07408336
Sponsor: AlphaNa Bioscience Company Limited
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Autoimmune Diseases

Start date: 2026-02-04
Primary completion: 2028-02-04
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.